According to the results of a study reanalyzing data obtained from an FDA review, , ranolazine potentiates the effects associated with ACE inhibitors, as well as angiotensin receptor blockers.

A new antiangina treatment will be distributed to pharmacies at the end of March. Ranolazine (Ranexa, CV Therapeutics) has antianginal and antiischemic effects that do not depend on reductions in ...

Ranolazine reduced episodes of stable angina in diabetes patients already receiving one or two antianginal drugs and led to less use of sublingual nitroglycerin, and the benefits appeared more ...

Jan. 20, 2004 -- Ranolazine improves exercise tolerance in patients with chronic angina already receiving standard doses of other medications, according to the results of a randomized, double-blind ...

This medication is an anti-anginal compound, prescribed for chest pain either alone or combined with other medication.

HealthDay News — Newer antianginal drugs (AA medications) such as ranolazine show substantial outcome improvements in chronic stable angina pectoris (CSA) compared to traditional medications, ...

Review the side-effects of Ranolazine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — A combination of ranolazine and dronedarone reduced atrial fibrillation burden better than ...

heart ecg arrhythmia The pharmacological properties of ranolazine, as well as evidence from clinical trials, suggest it may be beneficial in patients with atrial fibrillation. The pharmacological ...

Despite the availability of a number of antianginal agents, many patients with stable coronary artery disease (CAD) have persistent angina. Even following CABG surgery or percutaneous coronary ...